Addiction Science & Clinical Practice

Papers
(The median citation count of Addiction Science & Clinical Practice is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use76
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou55
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series49
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)39
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals36
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda33
Reimagining brief interventions for alcohol: towards a paradigm fit for the twenty first century?30
Patient perceptions of the use of e-cigarettes in smoking treatment programs: a qualitative analysis28
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial27
Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial27
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access26
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process24
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study23
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study23
“At least someone thinks I’m doing well”: a real-world evaluation of the quit-smoking app StopCoach for lower socio-economic status smokers20
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting20
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population19
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study19
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use17
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder17
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial17
Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study16
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State16
Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis16
Patient evaluation of a smartphone application for telehealth care of opioid use disorder16
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with metham15
What smartphone apps exist to support recovery from opioid use disorder? A content analysis of publicly available opioid-related smartphone apps15
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation14
“Take services to the people”: strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda14
Proceedings of the 18th Annual Conference of INEBRIA14
Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics13
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods13
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis13
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems13
“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits13
A systematic review of substance use screening in outpatient behavioral health settings12
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program12
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study12
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder12
Smoking cessation using preference-based tools: a mixed method pilot study of a novel intervention among smokers with low socioeconomic position11
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches11
A stakeholder-driven approach to designing a peer recovery coach role for implementation in community-oriented primary care teams in South Africa11
Automated Reinforcement Management System (ARMS): focused phase I provider feedback10
Substance use disorder bridge clinics: models, evidence, and future directions10
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions10
The development and initial validation of the Russian version of the BASIS-2410
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol9
Patient experiences of buprenorphine dispensing from a mobile medical unit9
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants9
Patient characteristics associated with their level of twelve-step attendance prior to entry into treatment for substance use disorders9
Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries8
Comparison of heroin and fentanyl use in US nationally representative surveys8
Rethinking trazodone for insomnia in alcohol use disorder8
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis8
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods8
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 20188
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey8
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder8
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d8
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky7
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design7
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology7
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule7
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial7
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care7
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec7
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services7
Attitudes and training related to substance use in pediatric emergency departments7
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative6
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder6
Improving alcohol health literacy and reducing alcohol consumption: recommendations for Germany6
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study6
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial6
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper6
Proceedings of the 17th Annual International INEBRIA Conference6
Subtypes and service utilization among opioid use disorder patients at a community health center: findings from a medically underserved urban area of the Northeastern United States6
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders6
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates6
The associations between public stigma and support for others’ help-seeking for alcohol use disorder: a cross sectional study in the general Danish population6
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography6
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versu6
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review6
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities6
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors6
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review6
Training health professionals to reduce overreporting of birthing people who use drugs to child welfare6
Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol5
Improving Treatment Together: a protocol for a multi-phase, community-based participatory, and co-design project to improve youth opioid treatment service experiences in British Columbia5
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services5
Grayken Lessons: a patient who developed opioid use disorder after traumatic brain injury5
Perspectives of healthcare workers on the integration of overdose detection technologies in acute care settings5
Study design to evaluate a web-intervention to prevent alcohol and cannabis-impaired driving and use among adolescents in driver education5
Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa5
“Just fighting for my life to stay alive”: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories5
Effects of service-wide support on regularity of alcohol screening of clients in Australian Aboriginal and Torres Strait Islander Community Controlled Health Services: a cluster randomised trial5
Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study5
Preliminary study of alcohol problem severity and response to brief intervention5
“It’s all about asking from those who have walked the path”: Patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa5
Prevalence and predictors of suicidality among adults initiating office-based buprenorphine5
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population5
Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study5
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway5
Ketamine-assisted buprenorphine initiation: a pilot case series5
Support after return to alcohol use: a mixed-methods study on how abstinence motivation and app use change after return to alcohol use in an app-based aftercare intervention for individuals with alcoh5
PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs5
Perceptions of family physicians in Istanbul about e-cigarettes as smoking cessation aids: a qualitative study4
Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trial4
Strategies for improving treatment retention for buprenorphine/naloxone for opioid use disorder: a qualitative study of issues and recommendations from prescribers4
Universal substance use care for adolescents with chronic medical conditions: a protocol to examine equitable implementation determinants and strategies for SBIRT at a pediatric hospital4
Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary4
‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians4
Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans4
Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related care4
Protecting patients and staff in residential treatment centers during exposure to COVID-19: commentary4
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis4
The Functional-Cognitive and Sensory Treatment (F-CaST) to improve rehabilitation outcomes of individuals with substance use disorder: a study protocol for a mixed-method randomized controlled trial4
Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum—20 years of research informing practice4
Expanding access to medications for opioid use disorder through locally-initiated implementation4
Supporting primary care clinicians in caring for patients with alcohol use disorder: study protocol for Records for Alcohol Care Enhancement (RACE), a factorial four-arm randomized trial4
Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study4
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County4
Correction to: A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program4
Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems4
Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study3
Case report: acute care management of severe opioid withdrawal with IV fentanyl3
Organization of primary care and early MOUD discontinuation3
Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients3
Improving the quality of counseling and clinical supervision in opioid treatment programs: how can technology help?3
Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model3
GHB: a life-threatening drug complications and outcome of GHB detoxification treatment—an observational clinical study3
A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder3
The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-di3
Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder3
Connect To Care (C2C): protocol for two-site randomized controlled pilot trial to improve outcomes for patients with hazardous drinking and PTSD and/or depression symptoms3
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy3
Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use3
A case of severe opioid and methamphetamine use disorder in a 14 year old3
Reasons for not seeking alcohol treatment among a sample of Florida adults with HIV who perceived the need for treatment3
Confidence in providing methadone maintenance treatment of primary care providers in Vietnam3
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review3
Provider perceptions of young people living with HIV and unhealthy alcohol use in Southwestern Uganda: a qualitative study3
Preoperative evaluation of alcohol consumption in older patients3
A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program3
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis3
Regaining control over alcohol intake but not abstinence on disulfiram medication, as a harm reduction approach: 2 case reports3
Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial3
A 13-item Health of the Nation Outcome Scale (HoNOS-13): validation by item response theory (IRT) in patients with substance use disorder2
Normalizing fentanyl: interpreting the perceived ‘risk’ of correctional officer work2
Psychometric properties of Fagerström Tolerance Questionnaire among Turkmen Nass (Naswar) users2
Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment2
The identification and treatment of alcohol problems in primary care (iTAPP) study: protocol for a stepped wedge cluster randomized control trial testing the 15-method in a primary care setting2
Augmenting project ECHO for opioid use disorder with data-informed quality improvement2
Implementation of a decentralized hepatitis C care pathway for people who use drugs in Dutch addiction care. Study protocol for the Hepatitis C: chain of addiction care (CAC) project2
A qualitative interview study of patient experiences of receiving motivational enhancement therapy in a Swedish addiction specialist treatment setting2
Acceptability of “DIDE”, a mobile application designed at facilitating care adherence of patients with substance use disorder2
Using intervention mapping for hookah smoking cessation: a quasi-experimental evaluation2
Combining app-based behavioral therapy with electronic cigarettes for smoking cessation: a study protocol for a single-arm mixed-methods pilot trial2
Correction: Do in-person and computer-based brief alcohol interventions reduce tobacco smoking among general hospital patients? Secondary outcomes from a randomized controlled trial2
How emergency departments are responding to the opioid crisis: Results from a statewide survey in Kentucky2
A personalized biomedical risk assessment infographic for people who smoke with COPD: a qualitative study2
Integrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial2
Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey2
A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder2
A Health Technician-delivered Brief Intervention linked to AUDIT for reduction of alcohol use in Chilean primary care: a randomized controlled trial2
Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016–20182
Inpatient detoxification for alcohol and other drug use: qualitative study of patients’ accounts of their relationships with staff2
Exploring perceptions of genetic risk and the transmission of substance use disorders2
An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report2
Alcohol use disorder with comorbid anxiety disorder: a case report and focused literature review2
Exploring barriers and facilitators to addressing hazardous alcohol use and AUD in mental health services: a qualitative study among Dutch professionals2
Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations2
HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England2
Barriers and facilitators to medication-assisted treatment for cocaine use disorder among men who have sex with men: a qualitative study2
Repetitive transcranial magnetic stimulation for stimulant use disorders (STIMULUS): protocol for a multi-site, double-blind, randomized controlled trial2
Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients with mental and physical disorders2
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis2
Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study2
Feasibility of precision smoking treatment in a low-income community setting: results of a pilot randomized controlled trial in The Southern Community Cohort Study2
Survey of Massachusetts peer recovery coaches’ attitudes toward the use of psychedelics to treat substance use disorders2
0.053915977478027